T
he breast implant may be the most important device ever developed in the field of plastic and reconstructive surgery. Despite half a century's worth of technological advances, the revision rate for breast prostheses remains high: 24 percent at 4 years and 36 percent at 10 years. 1 Many revisions are performed for soft-tissue-related problems, not for failure related to the device per se. Soft-tissue problems include capsular contracture and inadequate overlying tissue sometimes causing visibility of the device, a condition we define as "soft-tissue failure." Simply stated, one of the major drawbacks of breast implants is their unnatural appearance when the overlying softtissue volume is out of balance with implant volume.
Fat grafting to the breast has been met with increased enthusiasm since 2008, when the 1987 American Society of Plastic Surgeons moratorium was reversed. 2 This event allowed surgeons to actively manage the soft tissue of the breast, which has been reported by independent practitioners. [3] [4] [5] [6] While much of this early work with fat focused on core volume enhancement, there is a natural limitation to the projection achieved with fat alone due to its soft nature. Making the analogy to "mountains of sand," breast projection using only fat comes at the cost of a wide breast footprint, often wider than desired.
Background: A variety of suboptimal results arise in breast augmentation due to failure of the overlying soft tissue to adequately cover the implant. The authors describe a new concept of composite breast augmentation surgery that combines the core volume projection of breast implants with the natural look and feel of overlying fat. Methods: A total of 197 patients were treated over a 3-year period. This new approach was used when the overlying soft tissue was thin or insufficient to adequately cover the underlying prosthesis, in both breast implant revision and primary breast augmentation. In a subset of cases, quantitative three-dimensional breast imaging evaluated transplanted fat volume in the subcutaneous space of the breast. In primary cosmetic augmentation cases, preexpansion was not performed. In revision cases, preexpansion was performed to support the desired volume of fat required to achieve the aesthetic result. In a second subset of patients, preoperative and 1-year postoperative mammograms were evaluated by breast radiologists. Results: Fifty-seven percent of the volume of graft injected persisted at 1 year. Because fat provided soft-tissue implant coverage, there was less need to place the prosthesis beneath the muscle; many implants were placed in the subfascial plane. Evaluation revealed no cysts, masses, or fat necrosis, presumably because the recipient site was not overloaded with fat. Conclusions: Breast augmentation with simultaneous implants and fat affords a more powerful and versatile approach, and achieves a synergistic outcome. Composite breast augmentation should be added to the list of applications where fat grafting to the breasts may have clinical utility beyond simple core volume enhancement. (Plast. Reconstr. Surg. 132: 558, 2013.) This article introduces a new paradigm in breast surgery-a combination of classic implant teachings 7 and simultaneous management of the overlying soft tissue, a concept we define as "composite breast surgery." By incorporating both methods, one may achieve the core volume projection of an implant complemented by the natural look and feel of fat.
PATIENTS AND METHODS
Over a 5-year period, the authors performed breast augmentation using a combination of implants and fat on a total of 197 patients in 394 breasts. The procedures included 140 primary breast augmentations and 57 breast augmentation revisions. Patients were evaluated preoperatively and postoperatively with a combination of photographs, mammography, and quantitative three-dimensional breast imaging (Axis Three, Boston, Mass.).
Surgical Technique
Three scenarios for composite breast surgery were developed by three surgeons for the treatment of different recipient-site pathologies, illustrated by three examples below: (1) primary subglandular or subfascial breast implant placement with fat overlay; (2) primary submuscular breast implant placement using fat overlay; and (3) revision breast augmentation using implant exchange, pocket reassignment, and fat overlay.
Type 1: Subglandular or Subfascial Primary Breast Implant Augmentation and Fat Overlay
Clinical Examination A precise examination was conducted preoperatively, noting symmetry of the breasts and thorax, parenchymal density, the thickness of the breast tissue, and the distance between the clavicle and the areola as well as the distance between the areola and the inframammary fold. Most of the selected patients were thin with a body mass index under 20. However, it was possible to find adequate volumes of fat in these patients in the hip and flank region.
Drawings
With the patient in a standing position, markings were made in the midline and along the inframammary fold, following the previously described three-step principles. 8, 9 The planned dimensions and projection of the pocket were also marked according to the shape and diameter of the implant chosen. The area where the lipofilling would be performed after implantation was also carefully marked.
Liposuction
Liposuction was performed using a 3-mmdiameter cannula under one-half atmosphere machine suction into an "in-line" collection canister. The average amount of fat harvested from the thighs was 320 cc (range, 150 to 2000 cc). The harvested fat was placed into 10-cc syringes and centrifuged at 3000 rpm for 2 minutes. The oil and blood layers were discarded, and the remaining fat was used for fat grafting.
Device Implantation
Following previously published principles, 10 textured cohesive gel implants were placed in a retrofascial position through a 4-cm-long stairstep axillary incision (alternatively, implants were placed through a 4.5-cm inframammary crease incision in a subglandular position). Under direct visualization using a lighted retractor, the limits of the pocket were carefully dissected. The 51 round and 41 anatomical implants were placed in this manner. The average implant volume was 259 cc (range, 150 to 850 cc).
Fat Overlay
Adopting the principles described by Coleman, 11 injection of the graft was performed using a 15-cm-long, 1.5-mm-diameter cannula, with retrograde strings of fat placed superficially in the subcutaneous tissue ( Fig. 1) . In transaxillary cases, the thickest, most cranial part of the pectoralis fascia separated the surgical access to the implant pocket from the third space in order to compartmentalize the fat and kept the fat from entering the implant pocket. In a subglandular approach, lipofilling can be performed in the deep subcutaneous space only in areas peripheral to the implant, to avoid fat from migrating into the implant pocket. On average, 55 cc of fat was used to cover the implant in the superomedial transitional zones (55 cc per breast, 110 cc total).
Type 2: Submuscular Primary Breast Augmentation with Implants and Fat
Patients presenting for primary breast implant surgery had a combination of standard photography and preoperative volume measurements using three-dimensional imaging, and were evaluated using currently accepted soft-tissue planning methods. 12 When patients demonstrated thin breast subcutaneous tissue that would likely be insufficient to adequately cover the implants, they were counseled regarding composite breast augmentation. All patients who chose composite breast augmentation underwent screening mammography preoperatively. Patients with a strong family history of breast cancer were not offered composite breast augmentation. In the operating room, after the instillation of tumescent solution in a super-wet fashion, smooth round saline or gel implants were inserted via an inframammary crease incision or via the axilla. Gel implants placed via the axilla were introduced using a funnel device (Keller Medical, Stuart, Fla.). Fat was harvested using 3.5-or 4-mm-diameter, 12-hole cannulas and a machine "in line" collection of fat into sterile canisters. Fat was transferred into 60-cc syringes and dehydrated using a hand-crank centrifuge and low G-force spinning (the previously described "large syringe" technique 13 ) to remove unwanted blood and crystalloid. Fat grafting over the implants was performed using a 14-gauge, side hole, blunt-tipped injection cannula. Cannula insertion was facilitated using a 14-gauge sharp needle to traverse the skin. Two to three insertion sites were used in order to crosshatch fat deposition, with one site 1 cm inferior to the inframammary crease, another in the lateral pectoral region, and a third within the pigmented areola skin. A "reverse liposuction" technique was used to insert fat into the subcutaneous space. Fat was not injected directly into glandular tissue. The clinical endpoint resulted in a 1.5-to 2-cm soft-tissue thickening of the entire breast and surrounding transitional chest wall-implant interface. If desired, a temporary sizer was used so fat could be injected over a saline-filled sizer and not over a permanent implant (Figs. 2 and 3 ).
Type 3: Revision Breast Augmentation Using Implants and Fat
Revision patients often presented with partial or complete soft-tissue failure and had breast subcutaneous tissue with visible implant contours. The subcutaneous tissue was therefore insufficient as a recipient site for fat grafting without preoperative expansion. These patients underwent a program of preexpansion (Brava, LLC, Miami, Fla.) to significantly increase (two to three times) the volume of the subcutaneous tissue overlying the breast implant. Three-dimensional imaging was useful to document baseline breast volume and to monitor weekly progress of expansion to properly prepare the recipient site for surgery.
In the operating room, fat was harvested using 3.5-or 4-mm, 12-hole cannulas, and a machine powered "in line" collection of fat into sterile canisters. Fat was dehydrated using a hand-crank centrifuge and the large-syringe technique in a manner similar to that used for type 2 procedures. Fat grafting over the existing implant always preceded implant exchange to eliminate the risk of inadvertent damage to the new implant. Fat was introduced via 14-gauge, single side-hole injection cannulas in a manner similar to that used in type 2 procedures. If implants were originally placed in the subglandular position, they were reassigned to the submuscular position (Fig. 4) .
RESULTS
The follow-up period in the 197 patients ranged from 1 to 3.25 years, with a weighted average follow-up of 5 months. There were no infections, hematomas, cases of lateral pocket drift, or asymmetry of graft take. There were no cases of acute or long-term rupture of an implant due to any cause, including preexpansion and injection cannula trauma. Early complications included two cases of a cystic mass seen 2 to 3 months postoperatively that required aspiration of pale yellow material. Gram stain and culture were negative for bacteria and consistent with a sterile abscess of necrotic fat.
Late complications included a recurrent capsular contracture in a breast implant revision patient who was treated with composite breast augmentation, capsulotomy, and implant exchange for an existing capsular contracture. In primary cases, one capsular contracture was noted. Five primary cases required additional fat grafting for insufficient soft-tissue coverage. One patient demonstrated a donor-site deformity in the medial thigh that required revision in the form of fat grafting for a 2 × 3-cm 2 depression.
Mammographic Findings
Preoperative and 1-year postoperative mammograms were performed in a subset of 35 patients to evaluate the incidence of new calcifications, cysts, and masses. All cases that had postoperative mammograms were read by breast radiologists as being negative for pathologic findings. Mammograms were read as "implants with normal overlying breast tissue."
Quantitative Results of Volume Maintenance in Composite Breast Augmentation
In a subset of 20 consecutive patients treated with a simultaneous combination of submuscular implants and fat overlay, total breast volume was measured before and 1 year after surgery using three-dimensional breast imaging to quantify the persistence of volume and the percentage volume maintenance of transplanted fat (Fig. 5) . Volumes of transplanted fat and implant sizes were documented in operative notes at the time of surgery, allowing the calculation of residual volume maintenance after fat transplantation as follows:
(
Total Breast Volume Postop) -(Total Breast Volume Preop) -(Implant Volume) = Retained Volume
Percent Volume Maintenance = Retained Volume / Total Volume of Grafted Material A summary is shown in Table 1 .
DISCUSSION Composite Breast Augmentation: Soft-Tissue Planning with Soft Tissue
Soft-tissue analysis has emerged as a key driver of implant size selection and surgical technique. In cases of primary breast augmentation, current tissue-based planning standards call for appropriate-sized implants when the breast soft tissue is deficient, 14 or for differential implant sizes in cases of breast asymmetry. In revision breast augmentation surgery, current standards call for pocket reassignment, implant exchange and/or capsulorrhaphy, and skin removal surgery, with or without the use of acellular dermal matrix as a buffer between implant and insufficient soft tissue. 15 In cases of volumetric asymmetry, breast implants of different sizes are Figure 2 immediately after implant placement using 375-cc gel implants in the submuscular position, placed via the axilla, using the Keller Funnel (Keller Medical, Stuart, Fla.). (Below) The "composite moment" view of the left breast immediately after placement of 345 cc of fat over the implant in the subcutaneous space, or "third space, " of the breast, demonstrating the difference between implants alone and implants and fat. Note the more natural softness of the left breast and the left breast transitional zones, including the tail of Spence.
generally used, or soft-tissue differences are compensated for by differential resection of soft tissue.
The potential advantage of composite breast augmentation stems from the ability of the surgeon to impart customized shape and size change by working with two versatile and complementary media in two distinct planes. In composite breast augmentation, one can manage the core volume projection of an implant and achieve the natural look and feel of fat, with overlay and preferential fill where additional volume is required. Asymmetry of soft-tissue volume can be addressed with equal-sized implants and differential fat transplantation.
The versatility of implant placement affords three theoretical approaches and, therefore, three distinct "spaces" where equally versatile fat can be placed in composite breast augmentation. In submuscular breast augmentation with composite fat overlay, the muscle separates the implant from fat, and the third space spans from within the pectoralis muscle all the way to the superficial subcutaneous tissue. In subfascial implant placement with composite fat overlay, the pectoralis fascia separates the implant from the fat, and the third space ranges from immediately above the pectoralis fascia to the superficial subcutaneous tissue. Finally, if implants are placed in the subglandular position, above the pectoralis fascia, the third space is limited to the superficial subcutaneous fat, as deeper injection risks migration of fat into the implant pocket. A summary of these potential spaces is found in Table 2 and Figure 6 . Breast tissue is not found beneath the muscle; nor were the original implants placed there. 16 Indeed, the push to the submuscular plane probably stemmed from the inadequacy of breast soft tissue to effectively cover the prosthesis. With the versatility of composite breast augmentation, implants can be placed in the subfascial plane or even the subglandular plane, sparing the pectoralis muscle from overlay duties and avoiding potential animation and lateral drift deformities. Although the submuscular approach has been a workhorse solution, especially in the United States, where smooth round implants represent the majority of cases, there is potential for future breast augmentation strategies to rely less on the submuscular plane due to the composite strategy of implants and fat.
Radiological Follow-Up
Breast augmentation with fat has been condemned as causing calcifications and oil cysts that cannot be distinguished from malignancy, resulting in confusion, patient fear, and unnecessary biopsy. 17 The current findings suggest that the incidence of cysts and calcifications in fat grafting is low and the radiologic ability to effectively discern them is technique-dependent.
The mammographic findings suggest that fat transplanted in an overlay position over a prosthesis does not cause additional complexity to breast surveillance, as has been corroborated by others in the case of primary core augmentation with fat. 18 The low rate of calcifications seen on mammography in this series suggests that when fat is injected over implants, there is minimal evidence of fat necrosis. The incidence of fat necrosis in composite breast augmentation may be lower than that seen in core volume fat grafting because of lower volumetric demands on the capacity of the recipient site to host a proportionately smaller donor volume, resulting in more favorable diffusion characteristics. The diffusion characteristics of donor/recipient tissue in core volume versus composite overlay may be different, because the longest distance from the fascia or subdermal blood supply is much shorter in the composite scenario. As long as the recipient site is not overloaded, the grafting strategy seen in fat overlay lies on a spectrum between the diffusion dynamics of core volume breast augmentation with fat and a two-dimensional skin graft system.
Soft-Tissue Failure and the Use of Preexpansion
In revision cases utilizing composite breast augmentation, the capacity of the recipient site actually represents the pathology, as these patients demonstrate soft-tissue failure or inadequate soft tissue to cover their existing implants. The recipient site in the revision patient is therefore suitable for preexpansion using the Brava Table 1 (patient 12).
device. The device was useful and was therefore indicated in cases when the volumetric capacity of the recipient site was exceeded by the desired volume of graft needed to achieve the cosmetic outcome. Although the percentage volume maintenance was higher in the small subset of preexpanded patients (60 percent) than in primary, nonexpanded breast augmentation patients (53 percent), these results were not statistically different. Commercial ly available external expansion devices are currently used off label prior to fat grafting. In the current cases of revision breast surgery treated with the composite approach, such devices were also used off label. The potential risks and benefits of using external expansion devices over implants have been published previously 19 and have not been clinically shown to have deleterious effects on the underlying implant.
Volumes of fat needed to add sufficient thickness (utilizing radius measurements for standard implant sizes and assuming implant geometry to be that of an ellipse) can be calculated for a range of implants, as shown in Figure 7 .
For meaningful full-surface overlay, volumes of fat must approach volumes similar to those of the implants themselves. In cases where only specific quadrants of the breast require preferential fill, smaller volumes may be adequate.
Composite Breast Augmentation and the Overall Augmentation Landscape
In a group of patients presenting for cosmetic breast implant augmentation who have adequate breast soft tissue and favorable aesthetics, there is no need for additional fat overlay. This group of patients is best served by breast augmentation with implants alone, which is the accepted standard approach. The proportion of these "ideal" breast implant patients varies by practice, but certainly this group does not represent the sum total of patients seeking breast augmentation.
A different group of women exists who wish their breasts were larger but are not interested in having prosthetic breast implants. We define these individuals as the "padded bra" group, because in the United States, more than 58 million padded bras are purchased each year 20 in a $4.7 billion U.S. bra market. 21 By definition, these individuals desire their breast appearance to be larger but are not having breast augmentation. With the clarification of the clinical role of megavolume fat grafting to the breast, a subset of these women will likely opt for fat transplantation. If one percent of the padded bra group chooses "natural augmentation" with fat, primary core volume breast augmentation with fat would exceed 400,000 cases per year, an amount equal to the current number of aesthetic breast implant procedures performed annually in the United States. Because this group of patients would not otherwise seek implants, this group does not eliminate or compete in any way with the existing breast implant market.
One disadvantage of fat in core volume breast enhancement is its projection limitations. Because fat is a soft medium, like "mountains of sand," a wide base is required for adequate projection. Fat alone, as with implants alone, is not a perfect solution for all breast types (Fig. 8) . For everyone else, composite breast augmentation represents a solution for an unmet clinical need in cosmetic breast surgery-patients who desire breast implants but have inadequate soft tissue to cover their chosen size. Implants and fat, working together, provide the best attributes each has to offer: the core volume projection of implants and the natural look and feel of fat. The principles of composite breast augmentation may represent a viable option in the future of aesthetic breast surgery, pointing us in directions to refine our techniques for more consistent results and to achieve more natural outcomes for our patients. 
